Affimed NV Corporate Call Transcript
Good day, everyone, and welcome to Affimed's AFM24 Update Call. (Operator Instructions)
I would now like to introduce your host for day's call, Alex Fudukidis, Head of Investor Relations at Affimed. Please go ahead.
Thank you, Kevin, and thank you all for joining us for today's call to discuss the findings from the poster presentation of our AFM24 monotherapy study in non-small cell lung cancer that was presented earlier today by Dr. Anthony El-Khoueiry, Associate Director of Clinical Research at USC Norris Comprehensive Cancer Center and Principal Investigator of the AFM24 studies.
Before we begin, I'd like to remind everyone that we issued a press release earlier today and have since added the presentation that we will be using on this call, both of which can be found on the Investor Relations section of our website. On the call today, we have members of our management team, including Dr. Adi Hoess, our Chief Executive Officer; Dr. Andreas Harstrick, our Chief Medical
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
